Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracis

Abstract Objectives To evaluate the in vitro activity and in vivo efficacy of delafloxacin against Bacillus anthracis, the causative agent of anthrax. Methods MICs were obtained according to CLSI guidelines for 30 virulent isolates and 14 attenuated antibiotic-resistant strains. For the in vivo effi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of antimicrobial chemotherapy 2023-03, Vol.78 (3), p.810-816
Hauptverfasser:	McCurdy, Sandra, Halasohoris, Stephanie A, Babyak, Ashley L, Lembirik, Sanae, Hoover, Randall, Hickman, Mark, Scarff, Jennifer, Klimko, Christopher P, Cote, Christopher K, Meinig, J Matthew
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anthrax - drug therapy Anti-Bacterial Agents - therapeutic use Bacillus anthracis Ciprofloxacin Mice Microbial Sensitivity Tests
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!